9007

500672

NOVARTIND

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Novartis India Limited Share Price Today

NOVARTIS INDIA LIMITED is currently trading at ₹1387.2, up by ₹22.89 from the previous close. The stock touched an intraday high of ₹1394.00 and a low of ₹1356.80 during the latest trading session. Over the past one year, NOVARTIS INDIA LIMITED has delivered a return of 0.0%, while the stock has gained 15.6% in the last one month.

Novartis India Limited performance

Today’s low Today’s high
₹ 1356.80 ₹ 1394.00
₹ 1364.30
52 week low 52 week high
₹ 950.00 ₹ 1589.20
₹ 1364.30
Open Price ₹ 1371.20
Prev. Close ₹ 1364.30
Volume (Shares) 11042.00
Total traded value ₹ 150.64
Upper Circuit ₹ 1637.10
Lower Circuit ₹ 1091.50
info

Investment Returns

Over 1 Month 15.60% Over 3 Months 37.18% Over 6 Months 0.00% Over 1 Year 0.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Novartis India Limited fundamentals


  • Market cap (Cr) 3,368.60
  • P/E Ratio (TTM) 36.09
  • Beta -1.11
  • Book Value / share 331.23
  • Return on equity 13.19%
  • EPS (TTM) 37.74
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 25.25
info icon alternate text
  • Market cap (Cr) 3,371.00
  • P/E Ratio (TTM) 36.09
  • Beta 0.15
  • Book Value / share 331.23
  • Return on equity 13.19%
  • EPS (TTM) 37.74
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 25.25
info icon alternate text

Novartis India Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 90.55
Operating Expense 70.41
Net Profit 25.25
Net Profit Margin (%) 27.88
Earnings Per Share (EPS) 10.23
EBITDA 30.63
Effective Tax Rate (%) 16.22
Particulars DEC 2025 (Values in Cr)
Revenue 85.90
Operating Expense 65.00
Net Profit 16.09
Net Profit Margin (%) 18.73
Earnings Per Share (EPS) 6.52
EBITDA 31.11
Effective Tax Rate (%) 45.73
Particulars SEP 2025 (Values in Cr)
Revenue 90.33
Operating Expense 67.08
Net Profit 24.22
Net Profit Margin (%) 26.81
Earnings Per Share (EPS) 9.81
EBITDA 33.28
Effective Tax Rate (%) 25.81
Particulars JUN 2025 (Values in Cr)
Revenue 87.55
Operating Expense 60.94
Net Profit 27.62
Net Profit Margin (%) 31.54
Earnings Per Share (EPS) 11.19
EBITDA 37.85
Effective Tax Rate (%) 25.79
Particulars MAR 2025 (Values in Cr)
Revenue 83.88
Operating Expense 60.62
Net Profit 29.30
Net Profit Margin (%) 34.93
Earnings Per Share (EPS) 11.87
EBITDA 34.54
Effective Tax Rate (%) 13.54
Particulars MAR 2026 (Values in Cr)
Revenue 354.33
Operating Expense 263.44
Net Profit 93.18
Net Profit Margin (%) 26.29
Earnings Per Share (EPS) 37.74
EBITDA 132.86
Effective Tax Rate (%) 28.13
Particulars MAR 2025 (Values in Cr)
Revenue 356.27
Operating Expense 267.81
Net Profit 100.90
Net Profit Margin (%) 28.32
Earnings Per Share (EPS) 40.87
EBITDA 133.38
Effective Tax Rate (%) 22.63
Particulars MAR 2024 (Values in Cr)
Revenue 335.07
Operating Expense 273.91
Net Profit 85.19
Net Profit Margin (%) 25.42
Earnings Per Share (EPS) 34.50
EBITDA 126.94
Effective Tax Rate (%) 30.64
Particulars MAR 2023 (Values in Cr)
Revenue 378.74
Operating Expense 321.47
Net Profit 103.36
Net Profit Margin (%) 27.29
Earnings Per Share (EPS) 41.86
EBITDA 123.19
Effective Tax Rate (%) 10.41
Particulars MAR 2022 (Values in Cr)
Revenue 399.87
Operating Expense 387.24
Net Profit -3.72
Net Profit Margin (%) -0.93
Earnings Per Share (EPS) -1.51
EBITDA 10.66
Effective Tax Rate (%) 2.61
Particulars MAR 2025 (Values in Cr)
Book Value / Share 318.06
ROE % 13.19
ROCE % 16.64
Total Debt to Total Equity 0.01
EBITDA Margin 34.19
Particulars MAR 2024 (Values in Cr)
Book Value / Share 301.79
ROE % 11.21
ROCE % 15.57
Total Debt to Total Equity 0.02
EBITDA Margin 34.60
Particulars MAR 2023 (Values in Cr)
Book Value / Share 314.29
ROE % 14.09
ROCE % 14.88
Total Debt to Total Equity 0.03
EBITDA Margin 29.79
Particulars MAR 2022 (Values in Cr)
Book Value / Share 280.27
ROE % 5.84
ROCE % 5.66
Total Debt to Total Equity 0.06
EBITDA Margin 11.30
Particulars MAR 2021 (Values in Cr)
Book Value / Share 288.16
ROE % 2.92
ROCE % 5.57
Total Debt to Total Equity 0.09
EBITDA Margin 13.20
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 648.03
Total Assets 947.81
Total Liabilities 947.81
Total Equity 784.96
Share Outstanding 2
Price to Book Ratio 2.47
Return on Assets (%) 10.64
Return on Capital (%) 12.85
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 596.08
Total Assets 924.93
Total Liabilities 924.93
Total Equity 744.82
Share Outstanding 2
Price to Book Ratio 3.41
Return on Assets (%) 9.21
Return on Capital (%) 11.44
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 555.94
Total Assets 982.94
Total Liabilities 982.94
Total Equity 775.66
Share Outstanding 2
Price to Book Ratio 1.80
Return on Assets (%) 10.51
Return on Capital (%) 13.33
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 517.63
Total Assets 957.57
Total Liabilities 957.57
Total Equity 691.70
Share Outstanding 2
Price to Book Ratio 2.11
Return on Assets (%) -0.38
Return on Capital (%) -0.54
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 498.88
Total Assets 1002.29
Total Liabilities 1002.29
Total Equity 711.19
Share Outstanding 2
Price to Book Ratio 1.92
Return on Assets (%) 2.08
Return on Capital (%) 2.94
Particulars MAR 2024 (Values in Cr)
Net Income 122.84
Cash from Operations 75.13
Cash from Investing 33.13
Cash from Financing -120.99
Net change in Cash 25.54
Free Cash Flow 75.13
Particulars MAR 2023 (Values in Cr)
Net Income 115.38
Cash from Operations 42.46
Cash from Investing -153.25
Cash from Financing -30.48
Net change in Cash -138.93
Free Cash Flow 42.77
Particulars MAR 2022 (Values in Cr)
Net Income -3.82
Cash from Operations 57.26
Cash from Investing 87.04
Cash from Financing -35.63
Net change in Cash 90.08
Free Cash Flow 57.76
Particulars MAR 2021 (Values in Cr)
Net Income 40.04
Cash from Operations -34.02
Cash from Investing 95.16
Cash from Financing -36.80
Net change in Cash -10.85
Free Cash Flow -33.93
Particulars MAR 2020 (Values in Cr)
Net Income 28.64
Cash from Operations 14.99
Cash from Investing 55.91
Cash from Financing -41.41
Net change in Cash -8.64
Free Cash Flow 15.99
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENTERPRISES L 32.57 13.46 1.57 249.59 23.12 38.85
BLISS GVS PHARMA LTD. 474.55 38.52 4.21 5032.90 118.35 477.30
CIPLA LTD 1350.75 28.67 3.16 109119.71 1165.55 1672.20
FERMENTA BIOTECH LTD. 321.70 14.19 2.32 946.79 256.40 399.00
GLAXOSMITHKLINE PHARMACEUTICAL 2198.85 38.71 16.42 37249.85 2088.00 3500.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENTERPRISES L 32.57 22.78 4.19 249.59 23.12 38.85
AMRUTANJAN HEALTH CARE LTD. 536.40 24.04 4.18 1550.77 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8520.60 111.28 24.40 21301.50 7630.00 10395.35
BLISS GVS PHARMA LTD. 474.55 51.19 4.35 5032.90 118.35 477.30

Novartis India Limited shareholding pattern

Holding
28.61%
70.67%
0.17%
0.53%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

Novartis India Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
1364.30 -0.09 redarrow
red-green-graph indicator
4 Bearish
12 Bullish
  • 5 Days 1334.90
  • 26 Days 1293.60
  • 10 Days 1340.20
  • 50 Days 1176.70
  • 12 Days 1340.30
  • 100 Days 1023.80
  • 20 Days 1320.60
  • 200 Days 888.90
1348.37 PIVOT
First Support 1313.23 First Resistance 1400.73 Second Support 1260.87 Second Resistance 1435.87 Third Support 1225.73 Third Resistance 1488.23
RSI 57.39 ADX 32.78 MACD 46.69 Williams % R -70.51 Commodity Channel Index (CCI) -32.24
Date 2026-06-17 Week 8368.00 Same Day 8796.00 Month 16468.00
1 Year -1.11 3 Year -0.21
Over 1 Month
15.60% down
Over 1 Year
0.00% down
Over 3 Months
37.18% down
Over 3 Years
18.42% down
Over 6 Months
0.00% down
Over 5 Years
9.47% down

Novartis India Limited Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
23 Jul 2025 25.0 Final 23 Jul 2025 Equity shares
23 Jul 2024 25.0 Final 24 Jul 2024 Equity shares
20 Jul 2023 37.5 Special 21 Jul 2023 Equity shares
20 Jul 2023 10.0 Final 21 Jul 2023 Equity shares
20 Jul 2022 10.0 Final 22 Jul 2022 Equity shares
17 Aug 2021 10.0 Final 20 Aug 2021 Equity shares
29 Jul 2020 10.0 Final 31 Jul 2020 Equity shares
31 Jul 2019 10.0 Final 02 Aug 2019 Equity shares
18 Jul 2018 10.0 Final 20 Jul 2018 Equity shares
19 Jul 2017 10.0 Final 21 Jul 2017 Equity shares
21 Jul 2016 10.0 Final 22 Jul 2016 Equity shares
14 Jul 2015 10.0 Final 16 Jul 2015 Equity shares
16 Jul 2014 5.0 Final 18 Jul 2014 Equity shares
16 Jul 2013 10.0 Final 18 Jul 2013 Equity shares
18 Jul 2012 10.0 Final 20 Jul 2012 Equity shares
18 Jul 2011 10.0 Final 20 Jul 2011 Equity shares
21 Jul 2010 10.0 Final 23 Jul 2010 Equity shares
08 Jul 2009 10.0 Final 10 Jul 2009 Equity shares
07 Jul 2008 10.0 Final 09 Jul 2008 Equity shares
22 Mar 2007 10.0 Final 23 Mar 2007 Equity shares
20 Jul 2005 0.0 Final 22 Jul 2005 Equity shares
Dividend date Dividend amount Dividend type Record date Instrument type
23 Jul 2025 25.0 Final 23 Jul 2025 Equity shares
23 Jul 2024 25.0 Final 24 Jul 2024 Equity shares
20 Jul 2023 37.5 Special 21 Jul 2023 Equity shares
20 Jul 2023 10.0 Final 21 Jul 2023 Equity shares
20 Jul 2022 10.0 Final 22 Jul 2022 Equity shares
17 Aug 2021 10.0 Final 20 Aug 2021 Equity shares
29 Jul 2020 10.0 Final 31 Jul 2020 Equity shares
31 Jul 2019 10.0 Final 02 Aug 2019 Equity shares
18 Jul 2018 10.0 Final 20 Jul 2018 Equity shares
19 Jul 2017 10.0 Final 21 Jul 2017 Equity shares
21 Jul 2016 10.0 Final 22 Jul 2016 Equity shares
14 Jul 2015 10.0 Final 16 Jul 2015 Equity shares
16 Jul 2014 5.0 Final 18 Jul 2014 Equity shares
16 Jul 2013 10.0 Final 18 Jul 2013 Equity shares
18 Jul 2012 10.0 Final 20 Jul 2012 Equity shares
18 Jul 2011 10.0 Final 20 Jul 2011 Equity shares
21 Jul 2010 10.0 Final 23 Jul 2010 Equity shares
08 Jul 2009 10.0 Final 10 Jul 2009 Equity shares
07 Jul 2008 10.0 Final 09 Jul 2008 Equity shares
22 Mar 2007 10.0 Final 23 Mar 2007 Equity shares
20 Jul 2005 0.0 Final 22 Jul 2005 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Novartis India Ltd?

Answer Field

Novartis India Ltd share price is for NSE ₹ 1,387.20 & for BSE ₹ 1,391.40 as on Jun 19 2026 09:52 AM.

What is the Market Cap of Novartis India Ltd Share?

Answer Field

The market cap of Novartis India Ltd for NSE ₹ 3,368.60 & for BSE ₹ 0.00 as on Jun 19 2026 09:52 AM.

What is the 52 Week High and Low of Novartis India Ltd?

Answer Field

The 52 Week High and Low of Novartis India Ltd for NSE is ₹ 1,589.20 and ₹ 950.00 and for BSE is ₹ 1,588.40 and ₹ 750.00.

What is 1 year return for Novartis India Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Novartis India Ltd Share?

Answer Field

As on Jun 19 2026 09:52 AM the price-to-earnings (PE) ratio for Novartis India Ltd share is 36.09.

What is the PB ratio of Novartis India Ltd Share?

Answer Field

As on Jun 19 2026 09:52 AM, the price-to-book (PB) ratio for Novartis India Ltd share is 331.23.

How to Buy Novartis India Ltd Share?

Answer Field

You can trade in Novartis India Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Novartis India Ltd Share on Bajaj Broking App?

Answer Field

To buy Novartis India Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Novartis India Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|